Published in
Cell Press, Cell Reports, 1(35), p. 108959, 2021
DOI: 10.1016/j.celrep.2021.108959
Links
Tools
Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
Journal article published in 2021 by
Mark Dittmar 
,
Jae Seung Lee,
Kanupriya Whig,
Elisha Segrist,
Minghua Li ,
Brinda Kamalia,
Lauren Castellana,
Kasirajan Ayyanathan,
Fabian L. Cardenas-Diaz,
Edward E. Morrisey,
Rachel Truitt,
Wenli Yang,
Kellie Jurado,
Kirandeep Samby,
Holly Ramage
and other authors.
,
Jae Seung Lee,
Kanupriya Whig,
Elisha Segrist,
Minghua Li ,
Brinda Kamalia,
Lauren Castellana,
Kasirajan Ayyanathan,
Fabian L. Cardenas-Diaz,
Edward E. Morrisey,
Rachel Truitt,
Wenli Yang,
Kellie Jurado,
Kirandeep Samby,
Holly Ramage
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 